Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00955019 · ClinicalTrials.gov registry record
Novel Method of Surveillance in Barrett's Esophagus
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 180
- Enrollment target
NCT00955019: Completed study, sponsored by Mayo Clinic.
NCT00955019 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 180 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00955019 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 180 participants
- Enrollment target
Study Summary
This study is being done to see how biomarkers (abnormalities in molecules of cells ) present in their Barrett's esophagus agree with results from surveillance biopsies; and to compare three different brush devices used to collect cells to see which of these 3 brush devices obtains a higher number of cells.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2007-10 |
| Est. Completion | 2009-09 |
What the finished NCT00955019 record still lists
NCT00955019 is an observational study that tracks outcomes without assigning an intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00955019 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00955019 about?
NCT00955019 is a clinical study titled "Novel Method of Surveillance in Barrett's Esophagus". This study is being done to see how biomarkers (abnormalities in molecules of cells ) present in their Barrett's esophagus agree with results from surveillance biopsies; and to compare three different brush devices used to collect cells to see which of these 3 brush devices obtains a higher number o...
What is the current status of trial NCT00955019?
This trial is currently completed. The enrollment target is 180 participants. The study started on 2007-10. Estimated completion is 2009-09.
Who is sponsoring clinical trial NCT00955019?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia